“In silico Design and Computational Assessment of Small-Molecule GLP-1R Agonist as a Possible Treatment for Obesity and Type 2 Diabetes”, Tikrit J. Pharm. Sci., vol. 20, no. 1, pp. 51–66, Jun. 2026, doi: 10.25130/tjphs.2026.20.1.6.51.66.